{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:38:32Z","timestamp":1783535912320,"version":"3.55.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"The Rheumatological Research Fund"},{"name":"Frederiksberg Hospital"},{"name":"Skibsreder Per Henriksen R. & Hustru\u2019s Foundation"},{"name":"Eva Madura\u2019s Foundation"},{"name":"The Research Foundation of Copenhagen University Hospital"},{"name":"The Novo Nordic Foundation","award":["NNF15OC0014622"],"award-info":[{"award-number":["NNF15OC0014622"]}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["OCAY-13\u2013309"],"award-info":[{"award-number":["OCAY-13\u2013309"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Glucocorticoid treatment is fundamental in polymyalgia rheumatica (PMR) and giant cell arteritis (GCA), but carries a risk of glucocorticoid-induced adrenal insufficiency. Adrenal insufficiency can cause reluctance to stop glucocorticoid treatment after disease remission as symptoms can resemble PMR\/GCA flare. We aimed to determine the prevalence of adrenal insufficiency in prednisolone-treated patients with PMR\/GCA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We included 47 patients with PMR (n\u2009=\u200937), GCA (n\u2009=\u20091) or both (n\u2009=\u20099), treated with prednisolone for \u22655.4\u2009months, current dose 2.5\u201310\u2009mg\/day. Adrenal function was evaluated using a corticotropin (Synacthen\u00ae) stimulation test following 48\u2009h prednisolone pause. Two years\u2019 clinical follow-up data are provided.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Seven patients (15%) had adrenal insufficiency, 4 (11%) of the 37 patients with PMR alone, and 3 (30%) of the 10 patients with GCA. Corticotropin-stimulated P-cortisol was significantly associated with current prednisolone dose, mean daily dose the last 3 and 6\u2009months before testing, and basal P-cortisol, but not with total dose or treatment duration. Adrenal insufficiency occurred with all current prednisolone doses (2.5\u201310\u2009mg\/day). Five (71%) of the glucocorticoid-insufficient patients could discontinue prednisolone treatment; two of them recovered glucocorticoid function, whereas three still needed hydrocortisone replacement 2\u2009years later. Two patients experienced in total four acute hospital admissions with symptoms of adrenal crises.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Glucocorticoid-induced adrenal insufficiency occurred in 15% of patients with PMR\/GCA. Mean prednisolone dose the last 3\u2009months and basal P-cortisol were the best and simplest predictors of adrenal function. Most of the glucocorticoid-insufficient patients could discontinue prednisolone with appropriate treatment for adrenal insufficiency.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa011","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T12:10:25Z","timestamp":1578485425000},"page":"2764-2773","source":"Crossref","is-referenced-by-count":26,"title":["Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis\u2014prevalence and clinical approach"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3939-3388","authenticated-orcid":false,"given":"Stina W","family":"Borresen","sequence":"first","affiliation":[{"name":"Department of Medical Endocrinology, Copenhagen University Hospital, Rigshospitalet, Copenhagen"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toke B","family":"Thorgrimsen","sequence":"additional","affiliation":[{"name":"Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Bispebjerg and Frederiksberg, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Jensen","sequence":"additional","affiliation":[{"name":"Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Bispebjerg and Frederiksberg, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Hilsted","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen"},{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital, Rigshospitalet, Copenhagen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Else M","family":"Bartels","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Parker Institute, Copenhagen University Hospital Bispebjerg and Frederiksberg, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5903-3355","authenticated-orcid":false,"given":"Ulla","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[{"name":"Department of Medical Endocrinology, Copenhagen University Hospital, Rigshospitalet, Copenhagen"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5642-1117","authenticated-orcid":false,"given":"Henning","family":"Locht","sequence":"additional","affiliation":[{"name":"Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Bispebjerg and Frederiksberg, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"2020092605144004000_keaa011-B1","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"key":"2020092605144004000_keaa011-B2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","article-title":"BSR and BHPR guidelines for the management of polymyalgia rheumatica","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2020092605144004000_keaa011-B3","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2020092605144004000_keaa011-B4","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","article-title":"BSR and BHPR guidelines for the management of giant cell arteritis","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2020092605144004000_keaa011-B5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ejim.2013.05.014","article-title":"Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself","volume":"24","author":"Dinsen","year":"2013","journal-title":"Eur J Intern Med"},{"key":"2020092605144004000_keaa011-B6","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/EJE-14-0824","article-title":"Extensive expertise in endocrinology: adrenal crisis","volume":"172","author":"Allolio","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2020092605144004000_keaa011-B7","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0140-6736(13)61684-0","article-title":"Adrenal insufficiency","volume":"383","author":"Charmandari","year":"2014","journal-title":"Lancet"},{"key":"2020092605144004000_keaa011-B8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/ard.2010.133850","article-title":"Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus","volume":"70","author":"Dejaco","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2020092605144004000_keaa011-B9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0002-9343(85)90309-2","article-title":"Polymyalgia rheumatica. Duration of therapy and long-term outcome","volume":"79","author":"Ayoub","year":"1985","journal-title":"Am J Med"},{"key":"2020092605144004000_keaa011-B10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3899\/jrheum.141347","article-title":"Disease relapses among patients with giant cell arteritis: a prospective, longitudinal cohort study","volume":"42","author":"Kermani","year":"2015","journal-title":"J Rheumatol"},{"key":"2020092605144004000_keaa011-B11","first-page":"1","article-title":"Glucocorticoid withdrawal in polymyalgia rheumatica: the theory versus the practice","volume":"35","author":"Yates","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2020092605144004000_keaa011-B12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/030097401753180327","article-title":"Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis: a prospective two-year study in 273 patients","volume":"30","author":"Myklebust","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"2020092605144004000_keaa011-B13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/rheumatology\/kep395","article-title":"Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study","volume":"49","author":"Mackie","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2020092605144004000_keaa011-B14","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/ker017","article-title":"Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years","volume":"50","author":"Fardet","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2020092605144004000_keaa011-B15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1530\/EJE-17-0251","article-title":"Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritis","volume":"177","author":"Borresen","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2020092605144004000_keaa011-B16","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis","volume":"100","author":"Broersen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2020092605144004000_keaa011-B17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.semarthrit.2016.03.001","article-title":"Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review","volume":"46","author":"Joseph","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2020092605144004000_keaa011-B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/annotation\/66da2350-2981-489a-932d-3a456c8d0e49","article-title":"Recovery of adrenal function after long-term glucocorticoid therapy for giant cell arteritis: a cohort study","volume":"8","author":"Jamilloux","year":"2013","journal-title":"PLoS One"},{"key":"2020092605144004000_keaa011-B19","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.41.EP22","article-title":"Method-specific serum cortisol responses to the ACTH test: comparison of two generations of Roche automated immunoassays using polyclonal vs. MABs","author":"Klose","year":"2016","journal-title":"Endocr Abstr"},{"key":"2020092605144004000_keaa011-B20","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1210\/jc.2006-1791","article-title":"Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents","volume":"92","author":"Klose","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020092605144004000_keaa011-B21"},{"key":"2020092605144004000_keaa011-B22","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1210\/jc.2008-0710","article-title":"Corticotropin tests for hypothalamic-pituitary-adrenal insufficiency: a metaanalysis","volume":"93","author":"Kazlauskaite","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020092605144004000_keaa011-B23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MED.0b013e3282fdf16d","article-title":"Low-dose and high-dose adrenocorticotropin testing: indications and shortcomings","volume":"15","author":"Dickstein","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2020092605144004000_keaa011-B24","first-page":"838","article-title":"Comparison of the low dose short synacthen test (1 \u03bcg), the conventional dose short synacthen test (250 \u03bcg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease","volume":"84","author":"Abdu","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020092605144004000_keaa011-B25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/EJE-09-0746","article-title":"Technical details influence the diagnostic accuracy of the 1 \u03bcg ACTH stimulation test","volume":"162","author":"Wade","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2020092605144004000_keaa011-B26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2020092605144004000_keaa011-B27","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1210\/jc.2010-0982","article-title":"The diagnosis and management of central hypoadrenalism","volume":"95","author":"Grossman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020092605144004000_keaa011-B28","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfz180","article-title":"Adrenal insufficiency in kidney transplant patients during low-dose prednisolone therapy: a cross-sectional case-control study","author":"Valentin","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2020092605144004000_keaa011-B29","first-page":"1","article-title":"The effect of intra-articular injection of Diprospan at the knee joint on the hypothalamic-pituitary-adrenal axis","volume":"145","author":"Habib","year":"2015","journal-title":"Swiss Med Wkly"},{"key":"2020092605144004000_keaa011-B30","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1249\/mss.0b013e31805468d6","article-title":"High risk of adrenal insufficiency after a single articular steroid injection in athletes","volume":"39","author":"Duclos","year":"2007","journal-title":"Med Sci Sports Exerc"},{"key":"2020092605144004000_keaa011-B31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10067-013-2374-4","article-title":"Intra-articular methylprednisolone acetate injection at the knee joint and the hypothalamic-pituitary-adrenal axis: a randomized controlled study","volume":"33","author":"Habib","year":"2014","journal-title":"Clin Rheumatol"},{"key":"2020092605144004000_keaa011-B32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2310\/JIM.0000000000000048","article-title":"Simultaneous bilateral knee injection of methylprednisolone acetate and the hypothalamic-pituitary adrenal axis","volume":"62","author":"Habib","year":"2014","journal-title":"J Investig Med"},{"key":"2020092605144004000_keaa011-B33","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2310\/JIM.0b013e3182a67871","article-title":"The effect of intra-articular injection of betamethasone acetate\/betamethasone sodium phosphate at the knee joint on the hypothalamic-pituitary-adrenal axis: a case-controlled study","volume":"61","author":"Habib","year":"2013","journal-title":"J Investig Med"},{"key":"2020092605144004000_keaa011-B34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(99)06290-X","article-title":"Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment","volume":"355","author":"Henzen","year":"2000","journal-title":"Lancet"},{"key":"2020092605144004000_keaa011-B35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MED.0000000000000474","article-title":"Opioid induced adrenal insufficiency: what is new?","volume":"26","author":"Donegan","year":"2019","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2020092605144004000_keaa011-B36","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1210\/jc.2013-1394","article-title":"Pituitary-adrenal function after prolonged glucocorticoid therapy for systemic inflammatory disorders: an observational study","volume":"98","author":"Sacre","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020092605144004000_keaa011-B37","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1530\/EJE-09-0930","article-title":"Dexamethasone suppression test predicts later development of an impaired adrenal function after a 14-day course of prednisone in healthy volunteers","volume":"162","author":"Neidert","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2020092605144004000_keaa011-B38","first-page":"47","article-title":"Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals","volume":"83","author":"Huizenga","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020092605144004000_keaa011-B39","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrendo.2013.183","article-title":"Glucocorticoid sensitivity in health and disease","volume":"9","author":"Quax","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"2020092605144004000_keaa011-B40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJM199201233260403","article-title":"The effect of long-term glucocorticoid therapy on pituitary\u2013adrenal responses to exogenous corticotropin-releasing hormone","volume":"326","author":"Schlaghecke","year":"1992","journal-title":"N Engl J Med"},{"key":"2020092605144004000_keaa011-B41","first-page":"EP40","article-title":"Predictive baseline morning P-cortisol levels for the response to a Synacthen test in prednisolone treated patients","volume":"49","author":"Borresen","year":"2017","journal-title":"Endocr Abstr"},{"key":"2020092605144004000_keaa011-B42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/cen.13232","article-title":"Baseline morning cortisol level as a predictor of pituitary\u2013adrenal reserve: a comparison across three assays","volume":"86","author":"Sbardella","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020092605144004000_keaa011-B43","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1530\/EJE-15-0608","article-title":"Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol","volume":"173","author":"Woods","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2020092605144004000_keaa011-B44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/jc.2005-1131","article-title":"The long-term predictive accuracy of the short Synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis","volume":"91","author":"Agha","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020092605144004000_keaa011-B45","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1515\/cclm-2016-0400","article-title":"Multicenter performance evaluation of a second generation cortisol assay","volume":"55","author":"Vogeser","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"2020092605144004000_keaa011-B46","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1210\/jc.2017-02602","article-title":"The short cosyntropin test revisited: new normal reference range using LC-MS\/MS","volume":"103","author":"Ueland","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2020092605144004000_keaa011-B47","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ando.2016.05.002","article-title":"Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys\u00ae Cortisol II assay","volume":"77","author":"Raverot","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"key":"2020092605144004000_keaa011-B48","first-page":"1219","article-title":"Further evidence for insufficient hypothalamic-pituitary-glandular axes in polymyalgia rheumatica","volume":"33","author":"Straub","year":"2006","journal-title":"J Rheumatol"},{"key":"2020092605144004000_keaa011-B49","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/rheumatology\/39.6.624","article-title":"The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica","volume":"39","author":"Straub","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"2020092605144004000_keaa011-B50","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/annrheumdis-2013-203926","article-title":"TNF\u03b1 regulates cortisol metabolism in vivo in patients with inflammatory arthritis","volume":"74","author":"Nanus","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2020092605144004000_keaa011-B51","first-page":"1293","article-title":"Low serum levels of DHEAS in untreated polymyalgia rheumatica\/giant cell arteritis","volume":"33","author":"Narv\u00e1ez","year":"2006","journal-title":"J Rheumatol"},{"key":"2020092605144004000_keaa011-B52","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/ard.2009.126888","article-title":"Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis","volume":"69","author":"Buttgereit","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2020092605144004000_keaa011-B53","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1210\/jc.2011-1926","article-title":"Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation","volume":"97","author":"Johannsson","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020092605144004000_keaa011-B54","first-page":"3082","article-title":"Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning","volume":"84","author":"Plat","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020092605144004000_keaa011-B55","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/ard.27.4.352","article-title":"Corticosteroid-induced hypothalamo-pituitary-adrenal axis suppression. Prospective study using two regimens of corticosteroid therapy","volume":"27","author":"Jasani","year":"1968","journal-title":"Ann Rheum Dis"},{"key":"2020092605144004000_keaa011-B56","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/EJE-17-0340","article-title":"Higher glucocorticoid replacement doses are associated with increased mortality in patients with pituitary adenoma","volume":"177","author":"Hammarstrand","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2020092605144004000_keaa011-B57","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients","volume":"91","author":"Filipsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020092605144004000_keaa011-B58","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3899\/jrheum.100051","article-title":"Hypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with nighttime-release prednisone","volume":"37","author":"Alten","year":"2010","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/2764\/33794903\/keaa011.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/2764\/33794903\/keaa011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T09:15:12Z","timestamp":1601111712000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/10\/2764\/5730207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":58,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,2,7]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa011","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,2,7]]}}}